![](/img/cover-not-exists.png)
Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?
Bolarinde Ola, Masoud Afnan, Khaldoun Sharif, Nahed Hammadieh, Spyros Papaioannou, Aravinthan CoomarasamyVolume:
80
Year:
2001
Language:
english
Pages:
2
DOI:
10.1034/j.1600-0412.2001.801213.x
File:
PDF, 51 KB
english, 2001